Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Craniosynostosis v1.10 | ZNF462 | Zornitza Stark Phenotypes for gene: ZNF462 were changed from WEISS-KRUSZKA SYNDROME to Weiss-Kruszka syndrome, MIM#618619 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Craniosynostosis v0.74 | ZNF462 | Tiong Tan Marked gene: ZNF462 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Craniosynostosis v0.74 | ZNF462 | Tiong Tan Gene: znf462 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Craniosynostosis v0.74 | ZNF462 | Tiong Tan Classified gene: ZNF462 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Craniosynostosis v0.74 | ZNF462 | Tiong Tan Gene: znf462 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Craniosynostosis v0.73 | ZNF462 |
Tiong Tan gene: ZNF462 was added gene: ZNF462 was added to Craniosynostosis. Sources: Literature Mode of inheritance for gene: ZNF462 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: ZNF462 were set to 28513610 Phenotypes for gene: ZNF462 were set to WEISS-KRUSZKA SYNDROME Penetrance for gene: ZNF462 were set to Complete Review for gene: ZNF462 was set to GREEN Added comment: Craniosynostosis observed in 38% of affected individuals Sources: Literature |